Skip to content

Clinical trials

Withdrawn Phase 2/3 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Withdrawn Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20153
20172
20191
20201
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xijing Hospital2
Peking Union Medical College Hospital1
Peking University1
Peking University People's Hospital1
Ruijin Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai Mental Health Center1
Shenzhen People's Hospital1
Shi Ming1
Tianjin Medical University Cancer Institute and Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Aplastic1
Carcinoma, Hepatocellular1
Cognitive Dysfunction1
Diabetes Mellitus, Type 21
Esophageal Squamous Cell Carcinoma1
Hepatitis B1
Inflammation1
Obsessive-Compulsive Disorder1
Pancreatic Neoplasms1
Parkinson Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.